Delivery Order SPE2DB20D3103-SPE2DB25FM7E1

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,446.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PHENYLEPHRINE 2.5% EYE DROP 15ML, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a $2,068.26 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PHENYLEPHRINE 2.5% EYE DROP 2ML, a pharmaceutical product. The contract has a completion date of February 26, 2024 and was awarded on February 23, 2024. This contract is a delivery order issued under a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,642.35 firm fixed-price contract is for the supply of Phenylephrine 2.5% eye drops, with a performance period through April 26, 2023. No set-aside designation was used for this contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $2,242.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for PHENYLEPHRINE 2.5% EYE DROP 15ML, a medical product, with a period of performance through January 13, 2025. The contract is a Firm Fixed Price arrangement and was not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Phenylephrine 2.5% eye drops in 2ML vials, with a total ceiling value of $2,391.49 and a period of performance through January 22, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Phenylephrine 2.5% Eye Drops (15 mL) for a ceiling value of $1,088.25 and has a completion date of July 29, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,234.63 firm fixed-price contract is for the supply of Phenylephrine 2.5% eye drops, a medical product used in defense and civilian healthcare programs. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen is a for-profit company registered in the System for Award...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,730.97 firm fixed price delivery order contract (SPE2DB22D1106|SPE2DB24FEEY9) to provide 4563971207 - PHENYLEPHRINE 2.5% EYE DROP 15ML. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, awarded solely to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver...
This federal contract award, valued at $2,175.53, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a delivery order to supply Phenylephrine 2.5% eye drops (15ml) to the DLA. The contract is a firm-fixed price, with an ultimate completion date of February 18, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,098.82, is for the supply of Phenylephrine 2.5% eye drops with a completion date of January 21, 2025. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM7E1
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,965.36 firm fixed-price contract is for the delivery of PHENYLEPHRINE 2.5% EYE DROP 15ML to support federal medical institutions.

The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 12:03 PM